Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma

International Journal of Cancer

Volumn 136, Issue 4, 2015, Pages 761-770

  Li, Chiao Ling ^a   Yeh, Kun Huei ^a   Liu, Wan Hsin ^a   Chen, Chi Ling ^a   Chen, Ding Shinn ^a,b   Chen, Pei Jer ^a,b   Yeh, Shiou Hwei ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Estrogen; Gender; Hepatitis B virus; Hepatocellular carcinoma; Microrna; P53

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MICRORNA; MICRORNA 18A; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR ALPHA, HUMAN; MIRN18 MICRORNA, HUMAN; TP53 PROTEIN, HUMAN;

ADULT; ARTICLE; BIOGENESIS; CANCER SURVIVAL; CARCINOGENIC ACTIVITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUTANT; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA PROCESSING; SIGNAL TRANSDUCTION; SOMATIC MUTATION; UPREGULATION; WILD TYPE; AGED; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; MUTATION; RNA INTERFERENCE; SEXUAL DEVELOPMENT;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MUTATION; RNA INTERFERENCE; RNA PROCESSING, POST-TRANSCRIPTIONAL; SEX CHARACTERISTICS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84918838312     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29052     Document Type: Article

References (29)

1. Bosch FX, Ribes J, Cleries R, et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005; 9:191-211
2. Tan A, Yeh SH, Liu CJ, et al. Viral hepatocarcinogenesis: From infection to cancer. Liver Int 2008;28:175-88
3. Lee CM, Lu SN, Changchien CS, et al. Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer 1999;86:1143-50
4. Yeh SH, Chen PJ. Gender disparity of hepatocellular carcinoma: The roles of sex hormones. Oncology 2011;78 Suppl 1:172-9
5. Ruggieri A, Barbati C, Malorni W. Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity. Int J Cancer 2010; 127:499-504
6. Yu MW, Chang HC, Chang SC, et al. Role of reproductive factors in hepatocellular carcinoma: impact on hepatitis B- and C-related risk. Hepatology 2003;38:1393-400
7. Chiu CM, Yeh SH, Chen PJ, et al. Hepatitis B virus X protein enhances androgen receptorresponsive gene expression depending on androgen level. Proc Natl Acad Sci USA 2007;104: 2571-8
8. Yang WJ, Chang CJ, Yeh SH, et al. Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways. Hepatology 2009;49:1515-24
9. Wang SH, Yeh SH, Lin WH, et al. Identification of androgen response elements in the enhancer I of hepatitis B virus: A mechanism for sex disparity in chronic hepatitis B. Hepatology 2009;50: 1392-402
10. Wang SH, Yeh SH, Lin WH, et al. Estrogen receptor alpha represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4alpha. Gastroenterology 2012;142: 989-98 e4
11. Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317:121-4
12. Liu WH, Yeh SH, Lu CC, et al. MicroRNA-18a prevents estrogen receptor-Alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology 2009;136:683-93
13. Ota A, Tagawa H, Karnan S, et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 2004;64:3087-95
14. Newman MA, Hammond SM. Emerging paradigms of regulated microRNA processing. Genes Dev 2010;24:1086-92
15. Davis-Dusenbery BN, Hata A. Mechanisms of control of microRNA biogenesis. J Biochem 2010; 148:381-92
16. Gordo S, Martos V, Santos E, et al. Stability and structural recovery of the tetramerization domain of p53-R337H mutant induced by a designed templating ligand. Proc Natl Acad Sci USA 2008; 105:16426-31
17. Petitjean A, Mathe E, Kato S, et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 2007;28:622-9
18. Wang YC, Xu GL, Jia WD, et al. Protective effects of physiological doses of estrogen during hepatocarcinogenesis induced by diethylnitrosamine and N-nitrosomorpholine. Hepatogastroenterology 2011;58:2032-5
19. Xu H, Wei Y, Zhang Y, et al. Oestrogen attenuates tumour progression in hepatocellular carcinoma. J Pathol 2012;228:216-29
20. Riley T, Sontag E, Chen P, et al. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008;9:402-12
21. Fujimoto A, Totoki Y, Abe T, et al. Wholegenome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 2012;44:760-4
22. Guichard C, Amaddeo G, Imbeaud S, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012;44:694-8
23. Goh AM, Coffill CR, Lane DP. The role of mutant p53 in human cancer. J Pathol 2011;223:116-26
24. Bourdon JC, D'Errico A, Paterlini P, et al. p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation. Gastroenterology 1995;108:1176-82
25. Koskinas J, Petraki K, Kavantzas N, et al. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. J Viral Hepat 2005;12:635-41
26. Meek DW, Anderson CW. Posttranslational modification of p53: Cooperative integrators of function. Cold Spring Harb Perspect Biol 2009;1: A000950
27. Suzuki HI, Yamagata K, Sugimoto K, et al. Modulation of microRNA processing by p53. Nature 2009;460:529-33
28. Libri V, Miesen P, van Rij RP, et al. Regulation of microRNA biogenesis and turnover by animals and their viruses. Cell Mol Life Sci 2013;70:3525-44
29. Guil S, Caceres JF. The multifunctional RNAbinding protein hnRNP A1 is required for processing of miR-18a. Nat Struct Mol Biol 2007;14: 591-6.